StartupsPremiumIsomorphic Labs Raises $2.1 Billion as AI Drug Discovery Reaches Critical Mass
DeepMind spinout Isomorphic Labs has announced a $2.1 billion funding round, marking a decisive moment for AI-driven drug discovery. This massive capital injection suggests a structural shift in how the market values pharmaceutical research and development.